msuppli.bsky.social
MD. PhD. Clinical Oncologist, Zealand University Hospital 🇩🇰. Thoracic malignancies.
👤 Joined on 17 November 2024
Followers
Following
Total Posts
@msuppli.bsky.socialAdvances in the planning and delivery of radiation treatments have come from efforts to simultaneously reduce negative effects in normal tissues and enhance tumor control (seen in figure). Learn more: nej.md/4cjpcxk #MedSky
Show PostRussian military hiding as FPV drones inspects Russian position from the inside.
Show PostA 𝐦𝐢𝐭𝐨𝐜𝐡𝐨𝐧𝐝𝐫𝐢𝐨𝐧 is a cytoplasmic organelle that generates, through oxidative phosphorylation, molecules of ATP, a chemical used to store and generate energy for cellular functions, including proliferation. Full definition: nej.md/3IO75Tr #ScienceSky
Show PostLot to unpack from the excellent NORDIC NEC2. - ORR: 31% for NEC (mostly plat/eto) - this is NOT SCLC - ORR: 27% for G3 NETs (mostly TMZ-based) - Immediate progression: 41% of NECs, 21% G3 NETs - PFS: 3.4 m NEC; 7.4 G3 NET NECs are really bad cancers! www.nature.com/articles/s41...
Show PostA look at factors that predict disease progression after ICI toxicity in patients with lung cancer. Usual suspects (PD-L1, objective response, etc.). From @adamjschoenfeld.bsky.social Mark Awad @mskdeptofmed.bsky.social aacrjournals.org/clincancerre...
Show Post